{"name":"Promius Pharma, LLC","slug":"promius-pharma-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Comp03","genericName":"Comp03","slug":"comp03","indication":"Relapsing forms of multiple sclerosis","status":"phase_2"},{"name":"ACT01","genericName":"ACT01","slug":"act01","indication":"Relapsing forms of multiple sclerosis","status":"phase_2"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Cloderm Cream","genericName":"Cloderm Cream","slug":"cloderm-cream","indication":"Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses","status":"marketed"},{"name":"DFD06 Cream","genericName":"DFD06 Cream","slug":"dfd06-cream","indication":"Atopic dermatitis (eczema)","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Comp01","genericName":"Comp01","slug":"comp01","indication":"Other","status":"phase_2"},{"name":"Desonide Cream 0.05%","genericName":"Desonide Cream 0.05%","slug":"desonide-cream-0-05","indication":"Other","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Comp04","genericName":"Comp04","slug":"comp04","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"Comp03","genericName":"Comp03","slug":"comp03","phase":"phase_2","mechanism":"Comp03 is a small molecule that targets the S1P receptor.","indications":["Relapsing forms of multiple sclerosis"],"catalyst":""},{"name":"ACT01","genericName":"ACT01","slug":"act01","phase":"phase_2","mechanism":"ACT01 is a small molecule that targets the S1P receptor.","indications":["Relapsing forms of multiple sclerosis"],"catalyst":""},{"name":"Cloderm Cream","genericName":"Cloderm Cream","slug":"cloderm-cream","phase":"marketed","mechanism":"Cloderm Cream is a topical corticosteroid that reduces inflammation and suppresses immune responses in the skin.","indications":["Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses","Atopic dermatitis","Contact dermatitis","Seborrheic dermatitis"],"catalyst":""},{"name":"Comp01","genericName":"Comp01","slug":"comp01","phase":"phase_2","mechanism":"The mechanism of action for Comp01 is currently under investigation and not fully characterized.","indications":[],"catalyst":""},{"name":"Comp04","genericName":"Comp04","slug":"comp04","phase":"phase_2","mechanism":"Comp04 is a selective and potent inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Type 2 diabetes"],"catalyst":""},{"name":"DFD06 Cream","genericName":"DFD06 Cream","slug":"dfd06-cream","phase":"phase_3","mechanism":"DFD06 is a topical corticosteroid cream that reduces inflammation and immune-mediated skin responses by suppressing inflammatory cytokines and T-cell activation in dermatological conditions.","indications":["Atopic dermatitis (eczema)","Inflammatory dermatitis conditions"],"catalyst":""},{"name":"Desonide Cream 0.05%","genericName":"Desonide Cream 0.05%","slug":"desonide-cream-0-05","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5uVThTWnNLcnpvQ1NyRllrOXZTeW9FUlMyWmt0SmVzWmFnalJLVktqVTR4VnJSeHBTODM2SElBZDVqRXFjZjJSMlFHUTB3ZzdD?oc=5","date":"2022-03-26","type":"pipeline","source":"Dermatology Times","summary":"Tips for Discussing Nutrition with Patients - Dermatology Times","headline":"Tips for Discussing Nutrition with Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNVzdVcVFkLS1LZm1DZ2dBbzVld3JwMkdiMkNHNTZSb3ZhZEpDQ3Rta3FiOHJHVEpaV0kwVlVGaW5YSUJNZFY2bjJWN2Q3R2QwZFlnWURnUU8yWXlLbmhiRmJ4ZVhOOGJ5SkRQbGdtUXppbzBfeEQwQVlraWJLWXA4MGI0R09jR3dRbnh6Njk1UDRPNXdoVWhMdUZZeF9sTzhSZkdIMU5EVFhrNHo3YWNHQ2tB?oc=5","date":"2021-07-04","type":"regulatory","source":"Generics and Biosimilars Initiative","summary":"FDA approves generics from Amneal and Dr Reddy’s, and Natco submits ANDA - Generics and Biosimilars Initiative","headline":"FDA approves generics from Amneal and Dr Reddy’s, and Natco submits ANDA","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPUHpQVEdISzN2NlpNQUdzeTVsN1ZBRXZuLW1fM2FDRkdBRV9TMk8tVVFkMVlnc1F0X01sb1VOWFQ3S1dHczZmTWxaLTNma2tOdnZ2Z2NKYUV4QnVLd25UTGpsMFF4WGJPYnVzRWdfb1l2aTZJTGd0dllsSl9ha3JMOTc4VllDMXh0dXE4bHI4Um56ZFJwNEM5bDFtTUFYZkY0SXZOZnI4X2ptc2xhbFlGSXdXTERfSlZiY252eF90MGtoQ0RpeTltQVFGZzJkcVZJTkFkbWJFWXEwUDJvWWxuaEFOMm9aUXd2ZlY1d0xQNA?oc=5","date":"2019-06-14","type":"pipeline","source":"Healthcare Radius","summary":"Dr Reddy’s Laboratories announces entering into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLC - Healthcare Radius","headline":"Dr Reddy’s Laboratories announces entering into a definitive agreement to sell its neurology branded products to Upsher-","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQRnlnTWpLOTIySE1TT1FGdlNMWThNNXFNVlpQQWM3bks1ZDhwbEJkZ1BBNzIxeUJsZjBVZGRENGNsakdJUWZ3TWZMemZFbWwzenlfSHBHQW9GN2Zsd21EcENMdWxyZXNBSUVwZnQ5WnAtTFo0b1JYZWd1VTRZdVY4WXEzZmsxaDVlV2dtTWlvQ2ZRM3dUUHZqc9IBngFBVV95cUxPVmxxZXFmQXRaa2RweGItdUhxZ3FqOFcwUXlFRkxNZmpDRkJic2dnUFVoenQzQlp0STBoTlktNjlKUUstSW1oOVhlMUVKRGFXOU9mWWxUWUZWMEgzQWpsY3hUWVU3aWdacDEtb0hQX2lpMk9uTDZkY0FqUWxyRjJmMksxaVpJNHI4ZklYajc1QVp2NVVkeUdaQXdVZmV0dw?oc=5","date":"2018-10-04","type":"pipeline","source":"Express Pharma","summary":"DRL announces sale of Cloderm Cream, 0.1% franchise to EPI Health - Express Pharma","headline":"DRL announces sale of Cloderm Cream, 0.1% franchise to EPI Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ2UwanNwbXVVVkxsN18wVnk0dTFLTHp2eDRXdndmMmlKUDIydHhVMzNjbWhwZE9MZ3hsbVJpQW02N2FnWnk2UDh1dFc0bURyN2NXVFFTOHRqMFU2cGhPZVJWN1hGMTBrektCd2dkWHFmd2ZZWm0tb05GR0xNOEhDenRxWkdKSk02djhtZTFWbEhySkxPOVJzQ0x3bTEtZWvSAaQBQVVfeXFMUGl4bDltYUZRS3ExLVZ6b2M3azdRYUtWbmVQN1BSeW1TZlVIZkhoNTBDUV8yQ1JMQU1DSGxjUUpGVUhlZ1c3NGE2UFlnaE1DRVNuT2RRS0FXQ1J5aUxYUUp1eVJ5cDdvN2o1SFZtekRqeFY2VkhzUHlSVl8tbVZEaS1xaTF0dlJFUEFabWNYaFJQMmtQOVdGVjZLdVhlS09IZXZwNjE?oc=5","date":"2018-04-03","type":"pipeline","source":"Express Pharma","summary":"Promius Pharma files NDA for its migraine candidate - Express Pharma","headline":"Promius Pharma files NDA for its migraine candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPR2EtQmZsUTd0RG9WaGZTeXRlOGlXTklJUE54OXFtNVFyUTNjWHJ3S2pCTmlOWTBTMFY1cTljUEgtNTBZcENtRzdWQXAyM05YWUdPdlh6TkpVWTBnOFpmUzR2Wk1RQlY5cFBHdWxFZkU4d0RuMkVLY3AybklKTTZXREVicE5GcVJIVWg4WlVxSDBvTE53?oc=5","date":"2017-01-03","type":"patent","source":"Pharmaceutical Online","summary":"Atrix and Geneva Pharmaceuticals join forces on prescription generics development - Pharmaceutical Online","headline":"Atrix and Geneva Pharmaceuticals join forces on prescription generics development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQRWVHUXRGUGN4RXdMTWI1RkFLbVVTbjdLLUJESDZLb0Q2UzFuZ1cyUE9mWWI3R1pkSW5OZ19VajlVak1LYTBNR0FqZWx0RWZZOFpVSnVLVGZ6MkJJcjFwam9hRWt3Q1NXMzJ0SG5BczZDZktzYkhhX3AtMkNfdlFrQVRMQ2Y3MzhqQXJ5Mm9xYTc?oc=5","date":"2016-07-22","type":"pipeline","source":"Drug Store News","summary":"Promius Pharma launches new corporate brand identity - Drug Store News","headline":"Promius Pharma launches new corporate brand identity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQRnY0eGpMZWxlc3VGOG4xTEZMaklnZXZFZ0pTTmNZdS1VQUg1eGl3cVVxbm1fOEVCYVgyQzRtTU1nTHNPcm94dGl2TjQ3d3ZZTm9SakI0cWxGSVZJWVF0TTZiS0NtNU0yM1g2MHFScVZjblVsZVZlTlBVa0xLOFpPMVY4NWhac2FTTGZmZTdPeDlOb0VSdmFvTkIyMV90R0tvVlhQbDFRYzFnamhORGo4M3RsT3lNcU94aDk0QkduU2huamZvQi1wVWFn0gHPAUFVX3lxTE54cmNmNlMtcG9ZNFEtX1NBdk5lcThKa3owVlF0Wi1nYjIzRnFhVjNmMEROTkZjSlFwQUIzVWdQVjFWWmlnRlJXU3JEV1ZkSS1MWFp0azFKUUFnelNyLVRVUVZod3FONzlmT0paVENTZk5jSzk4TkdqUGlIMGRVaFVFc1VabmI2ZWljSDYwa29wU3pleFFsMVoyaGs5YWlSRTh4eF9Id0M2MTZMREFpcURURkVhTHlGNDV5UENKYzAyQ0syZmtVTUdhQlpUc2VZYw?oc=5","date":"2016-04-19","type":"pipeline","source":"Business Standard","summary":"Dr Reddy's launches migraine drug Zembrace SymTouch in US - Business Standard","headline":"Dr Reddy's launches migraine drug Zembrace SymTouch in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOLWxvYkEwdEN1NkdYV3BrSHZJRndhQlRDc0xiR1FEaTZMT3JSNnN4X3hYTUd4WXpjQ3ZQWFBDTDc3bXJCLWV0S0dEVWtlaEhyTi1rc0tqaHUteV9ab1VoVERrWkJyUWRJRGIwUDlrWjJ3TzBjMXdSVEphTkpVRlZRT2haOFl1bnFkLTFDNlM2ZWN3c0lDaFBXWjV2RdIBoAFBVV95cUxNQVpGOVpKZ2NRMFE4aHB2TXIzWGlkNW9lOVhjTVhVV0h0Z3d3cEhkMU1xckl2Skp1NVI2TUVUb3ZuRFd2YWpaU29GWFBnQzdoeFowZUZDZGJYLVFsQmFnQU40b1c5TGNUX1R5Y2FPMnY2Wi0xNFN4MzlZZ3NiYXR3S1g3N1h4dHgwTUc2c0Y3dGpFRjdUZWFxSndvNno5YmJQ?oc=5","date":"2016-02-01","type":"regulatory","source":"India.Com","summary":"Dr Reddy's gets tentative approval from USFDA for Zenavod - India.Com","headline":"Dr Reddy's gets tentative approval from USFDA for Zenavod","sentiment":"positive"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_2":4,"marketed":2,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}